Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research project RISC-RAD’s annual meeting contributes to change the way we see ionizing radiations.

18.05.2006


Throughout our life, we are exposed daily to ionizing radiation (IR) emitted by Earth, during routine medical diagnosis exams, or in the workplace for professionals such as nuclear workers but also cabin crew members of airline companies. How aware is the public of being exposed to low doses of IR? Accounting for about 2,4 mSv/year/person, these unperceived exposures to IR are considered harmless by radiation protection standards based on biological effects the current state of science allows to detect...

But how to be sure that what you can not see does not exist? Part of the answer is expected to come from European research project RISC-RAD (Radiosensitivity of Individuals and Susceptibility to Cancer induced by Ionizing Radiations), which just held its midterm meeting in Leiden, The Netherlands, from 4 to 6 May 2006. This four-year project funded by the European Commission (EC) started on 1st January 2004 and addresses the challenging issue of cancer risk assessment at low doses of IR.

“Under the dose of 100 mSv, epidemiological studies failed to demonstrate long term effects on organisms of exposure to ionizing radiations, because, if they exist, these effects are masked by the high cancer incidence of 25 % in the population”, explains Laure Sabatier, coordinator of RISC-RAD and head of the Radiobiology and Oncology Lab in the French Atomic Energy Commission. “This is why a biological approach is needed, starting with improving our understanding of the mechanisms by which ionizing radiation induce cancer”. Ionizing radiation act as a stress on cells, provoking immediate lesions on DNA double-helix, including strand breaks associated with base modifications. Since Hiroshima and Nagasaki bombings, long term effects of exposure to IR are known to be cancers.



“The mechanisms by which immediate effects of IR lead to long term effects some twenty years later remain unclear” says Dr. Sabatier. Gathering 80 scientists in 29 research institutes from 11 countries, the second RISC-RAD annual meeting in Leiden allowed partners to measure the knowledge gained. In 2005, 72 publications in international scientific journals were achieved through RISC-RAD funding. Some major findings concerned role of Artemis protein in the repair of clustered DNA lesions, consequences of loss to a single telomere in genomic instability, identification of new genes influencing susceptibility to tumorigenesis, and improvement of mathematical models for biological responses to IR. The unique scope of areas covered by these publications was made possible by integrating European research efforts in low dose research into a single project, whose cost is estimated at 30 million euros. RISC-RAD comes under EC 6th Framework Programme for research within EURATOM treaty, which promotes a safe use of nuclear power, including the protection of man and the environment.

The results obtained so far within RISC-RAD show a growing body of evidence that genetic variations could induce differences of response to exposure to IR between individuals. In other words, the same low dose of IR could do no harm at all to some people, and induce a cancer on others, depending on their genetic background. Identification of new genes involved in radiosensitivity is part of RISC-RAD. A critical issue for radiation protection is to be able to assess individual risk taking in account genetic parameters, and not only the average risk as estimated by epidemiological studies.

“The strong point of RISC-RAD is that experimentalists and modelers are working hand in hand to infuse new biological findings into predictive mathematical models” explains Dr. Sabatier. “Thanks to RISC-RAD, the way we see ionizing radiation is changing. Far from being a blessing when it comes to radiotherapy or a plague when it comes to nuclear power, IR are anyway part of our natural environment at low doses. Understanding the mechanisms through which they jeopardize human health will enable to adapt radioprotection standards to individual cases and to promote a safer use of radiations”.

Axel Meunier | alfa
Further information:
http://www.riscrad.org

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>